The discovery of VU0486846: steep SAR from a series of M PAMs based on a novel benzomorpholine core.

Bioorganic & Medicinal Chemistry Letters(2018)

引用 9|浏览29
暂无评分
摘要
•Detailed SAR leading to an M1 PAM devoid of cholinergic liability.•Enhanced sp3 character and enantiospecific M1 PAM activity.•Unexpected SAR form the fluorine walk strategy.
更多
查看译文
关键词
M1,Muscarinic acetylcholine receptor,Positive allosteric modulator (PAM),Schizophrenia,Structure-Activity Relationship (SAR)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要